Health Catalyst, Inc. (Nasdaq: HCAT) has recently acquired Carevive Systems, a health technology company based in Boston, MA. The financial details of the acquisition were not disclosed, but this move will enable Health Catalyst to improve its support for care and process enhancements in oncology. Additionally, the acquisition will provide Health Catalyst with new insights into patient-reported outcomes and oncology registry data.
Carevive Systems offers a flagship platform that integrates data into routine clinical practice for various aspects of cancer care. This includes treatment care planning, clinical trial screening, care coordination, remote patient monitoring, and post-treatment care. With this acquisition, Health Catalyst aims to expand its oncology-focused technology offerings and enhance its ability to support data-driven improvements in healthcare organizations.
Health Catalyst is under the leadership of CEO Dan Burton and provides data and analytics technology and services for healthcare organizations. Their cloud-based data platform, analytics software, and professional services aim to be a catalyst for data-informed healthcare improvement through their ability to collect and analyze large volumes of patient data. With over 100 million patient records in their database, they are able to make data-informed decisions that result in measurable improvements in clinical, financial, and operational outcomes for their customers.
Overall, this strategic move by Health Catalyst represents an opportunity to improve their oncology-focused technology offerings while strengthening their ability to support data-driven improvements in healthcare organizations through the integration of Carevive Systems’ advanced technologies.
